ask="0.6666"
ask_size="2500"
average_daily_volume="535397"
bid="N/A"
bid_size="N/A"
book_value="0.8130"
change="-0.0199"
change_from_200_day_moving_average="0.0133"
change_from_50_day_moving_average="-0.0470"
change_from_52_week_high="-0.8998"
change_From_52_week_low="0.1891"
change_in_percent="-3.6852%"
close="0.5201"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.5350"
ebitda="-17.93M"
eps_estimate_current_year="-0.7800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.5700"
ex_dividend_date="N/A"
float_shares="29628000"
high="0.5400"
high_52_weeks="1.4199"
last_trade_date="3/7/2017"
last_trade_price="0.5201"
last_trade_size="100"
last_trade_time="3:58pm"
low="0.4809"
low_52_weeks="0.3310"
market_capitalization="15.61M"
moving_average_200_day="0.5068"
moving_average_50_day="0.5671"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.9000"
open="0.5200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+2.6314%"
percent_change_from_50_day_moving_average="-8.2947%"
percent_change_from_52_week_high="-63.3707%"
percent_change_from_52_week_low="+57.1299%"
previous_close="0.5400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.6642"
price_per_sales="1.4623"
revenue="11.09M"
shares_outstanding="30020000"
short_ratio="4.0600"
stock_exchange="NCM"
symbol="OGXI"
volume="230291"
weeks_range_52="0.3310 - 1.4199"
